Evidence map›Paper›PMID 39772695›Full record

ArticleScience advances2025

Blocking the isoflavone chemoreceptor in

Peiyun Ji, Yazhou Bao, Hao Zhou, Yong Pei, Wen Song, Kangmiao Ou, Zijin Qiao, Jierui Si, Zengtao Zhong, Xia Xu and 4 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Metabolomics navigates natural variation in pathogen-induced secondary metabolism across soybean cultivar populations.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Peiyun JiDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0002-8475-2503
Yazhou BaoAcademy for Advanced Interdisciplinary Studies, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-6679-1018
Hao ZhouDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.
Yong PeiDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.
Wen SongDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.
Kangmiao OuCollege of Life Sciences, Nanjing Agricultural University, Nanjing 210095, China.
Zijin QiaoDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.
Jierui SiDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.
Zengtao ZhongCollege of Life Sciences, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0003-0223-8875
Xia XuHefei Kejing Biotechnology Co., Ltd., Hefei 230061, China.
Tao HuangHefei Kejing Biotechnology Co., Ltd., Hefei 230061, China.
Danyu ShenDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0002-2973-0010
Zhiyuan YinDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0002-7189-895X
Daolong DouDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-5226-6642

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibiting pathogen chemotaxis is a promising strategy for reducing disease pressure. However, this strategy is currently in the proof-of-concept stage. Here,

Indexed as

ChemotaxisGenisteinPhytophthoraPlant DiseasesGlycine maxIsoflavonesPhosphorylationProtein BindingGenisteinIsoflavones

Identifiers

PMID39772695
PMCPMC11708900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.